Firefly Neuroscience Changes Auditors
Ticker: AIFF · Form: 8-K · Filed: Nov 1, 2024 · CIK: 803578
Sentiment: neutral
Topics: auditor-change, accounting
TL;DR
Firefly Neuroscience swapped auditors from WithumSmith+Brown to CohnReznick. No fireworks, just a routine change.
AI Summary
Firefly Neuroscience, Inc. filed an 8-K on October 29, 2024, to report changes in its certifying accountant. The company is changing its independent registered public accounting firm from WithumSmith+Brown, PC to CohnReznick LLP, effective October 25, 2024. This change was approved by the Audit Committee of the Board of Directors.
Why It Matters
A change in auditors can sometimes signal underlying issues or a strategic shift within a company, warranting closer examination of the reasons behind the transition.
Risk Assessment
Risk Level: low — The filing solely reports a change in the company's independent auditor, which is a routine administrative event.
Key Players & Entities
- Firefly Neuroscience, Inc. (company) — Registrant
- WithumSmith+Brown, PC (company) — Former Certifying Accountant
- CohnReznick LLP (company) — New Certifying Accountant
- October 29, 2024 (date) — Date of Report
- October 25, 2024 (date) — Effective Date of Auditor Change
FAQ
Who was Firefly Neuroscience, Inc.'s previous independent auditor?
Firefly Neuroscience, Inc.'s previous independent auditor was WithumSmith+Brown, PC.
Who is Firefly Neuroscience, Inc.'s new independent auditor?
Firefly Neuroscience, Inc.'s new independent auditor is CohnReznick LLP.
When did the change in auditors become effective?
The change in auditors became effective on October 25, 2024.
Who approved the change in certifying accountant?
The change in certifying accountant was approved by the Audit Committee of the Board of Directors.
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a change in the registrant's certifying accountant.
Filing Stats: 908 words · 4 min read · ~3 pages · Grade level 15.7 · Accepted 2024-11-01 16:05:33
Key Financial Figures
- $0.0001 — on which registered Common Stock , $0.0001 par value per share AIFF The Nasdaq
Filing Documents
- wavd20241029_8k.htm (8-K) — 36KB
- ex_740828.htm (EX-16.1) — 4KB
- footer.jpg (GRAPHIC) — 11KB
- logo.jpg (GRAPHIC) — 7KB
- 0001437749-24-032977.txt ( ) — 196KB
- wavd-20241029.xsd (EX-101.SCH) — 3KB
- wavd-20241029_def.xml (EX-101.DEF) — 11KB
- wavd-20241029_lab.xml (EX-101.LAB) — 15KB
- wavd-20241029_pre.xml (EX-101.PRE) — 11KB
- wavd20241029_8k_htm.xml (XML) — 3KB
01
Item 4.01 Changes in Registrant ' s Certifying Accountant. (a) Dismissal of Independent Registered Public Accounting Firm On October 29, 2024, the Audit Committee (the " Audit Committee ") of the Board of Directors of Firefly Neuroscience, Inc. (the " Company ") dismissed Turner, Stone & Company LLP (" Turner Stone ") as the Company's independent registered public accounting firm, effective immediately. The reports of Turner Stone on the Company's consolidated financial statements for the years ended December 31, 2023, and December 31, 2022, did not contain an adverse opinion or a disclaimer of opinion, and was not qualified or modified as to uncertainty, audit scope, or accounting principles, except that Turner Stone's reports for the years ended December 31, 2023, and December 31, 2022, each contained an explanatory paragraph stating there was substantial doubt about the Company's ability to continue as a going concern. During the two most recent fiscal years ended December 31, 2023, and December 31, 2022, and the subsequent interim period through October 29, 2024, there were no disagreements (as defined in Item 304(a)(1)(iv) of Regulation S-K of the Securities Exchange Act of 1934, as amended (" Regulation S-K ") and the related instructions to Item 304 of Regulation S-K) with Turner Stone on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Turner Stone, would have caused Turner Stone to make reference to the subject matter of the disagreements in connection with its reports on the Company's consolidated financial statements for such years. Also during this time, there were no "reportable events," as defined in Item 304(a)(1)(v) of Regulation S-K. The Company provided Turner Stone with a copy of the above disclosures and requested that Turner Stone furnish the Company with a letter addressed to the Securities and Exchange Commissio
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description of Exhibit 16.1 Letter from Turner, Stone & Company LLP to the Securities and Exchange Commission dated October 31, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. FIREFLY NEUROSCIENCE, INC. Date: November 1, 2024 By: /s/ Jon Olsen Name: Jon Olsen Title: Chief Executive Officer